News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Affymax, Inc. (AFFY) CEO Arlene Morris Joins Nuon Therapeutics Inc.'s Board of Directors as Chair



7/16/2009 9:26:09 AM

SAN MATEO, Calif.--(BUSINESS WIRE)--Nuon Therapeutics, Inc., a clinical stage, privately-held biopharmaceutical company focused on novel therapies for autoimmune and inflammatory diseases, announced today that Arlene Morris, president and CEO of Affymax, Inc. (Nasdaq:AFFY), has been elected chairperson of the company’s Board of Directors. A proven commercial leader in the biotechnology and pharmaceutical industry with more than 25 years of experience, Ms. Morris is well suited to work with the management team at Nuon Therapeutics.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES